source
- FDA approves Lilly's once-weekly basal insulin Onswik for adults with type 2 diabetesThe U.S. Food and Drug Administration has granted approval to Eli Lilly’s Onswik, a basal insulin designed for once-weekly injection in adults with type 2 diabetes. The new formulation offers patie…
- Adicet Bio's off-the-shelf CAR-T therapy shows lupus remission in early Phase 1 trialAdicet Bio reported that its off-the-shelf CAR-T product prula-cel induced remission in more than half of lupus patients enrolled in a small Phase 1 study. One year after a single infusion, 12 of…